Metronidazol Noridem Enterprises

Metronidazole, the active ingredient in Metronidazol Noridem Enterprises, is a nitroimidazole antibiotic presented as an injectable solution for intravenous use. It treats anaerobic bacterial and protozoal infections in adults and children as prescribed.

GNH USA supplies Metronidazol Noridem Enterprises as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is employed to eradicate anaerobic bacteria and protozoa across several infection types.

- Bacterial vaginosis: eliminates the anaerobic flora responsible for symptoms and recurrence. - Trichomoniasis: destroys Trichomonas vaginalis, relieving genital irritation. - Amoebiasis: eradicates Entamoeba histolytica trophozoites, preventing intestinal disease. - Giardiasis: clears Giardia lamblia infection, reducing diarrheal episodes. - Anaerobic bacterial infections: targets a broad range of anaerobes in intra‑abdominal, skin and dental infections. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding clinical resolution.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: occasional dull or throbbing pain. - Diarrhea: loose stools that may be self‑limiting. - Abdominal pain: cramping or discomfort. - Dizziness: light‑headed feeling, especially on standing.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Stevens‑Johnson syndrome: severe skin blistering. - Pancytopenia: reduction in blood cell counts. - Hepatotoxicity: elevated liver enzymes or jaundice.

Before initiating therapy, clinicians should evaluate patient‑specific factors and follow safe handling practices.

- Renal function assessment: adjust dosing in impaired kidneys. - Hepatic monitoring: watch for liver enzyme elevation. - Alcohol avoidance: prevent disulfiram‑like reactions. - Pregnancy consideration: use only if benefits outweigh unknown risks. - Hypersensitivity screening: discontinue if allergic signs appear. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Metronidazole can alter the activity of several co‑administered drugs; careful review is required.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, tachycardia, and hypotension. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: can raise serum lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Phenytoin: may reduce metronidazole concentrations. - Cimetidine: can increase metronidazole plasma levels, requiring observation.